Relationship between the serum complement receptor 1 of patients with hepatitis gravis and the degree of liver damage

Zhang JiWan; Wang HaiBin; Zhou JianLi; Liu TongFa; He PengFei; Wang YeDong; Zhang HaiLing; Long Li; Wang BinRong

Issue 3

Mar. 2003

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2003 > 19(3): 174-175

PDF( 119 KB)

重型肝炎患者血清sCR1与肝功能损伤程度的相关性研究

Published Date: 2003-03-20

Abstract

Abstract

To study the changes and the clinical significance of serum complement receptor 1 (sCR1) of patients with hepatitis gravis. Enzyme-linked immuno-sorbent assay (ELISA) was used to analysis 30 cases with hepatitis gravis, 46 cases with chronic viral hepatitis and 30 control cases. It suggested that sCR1 of patients with hepatitis gravis or chronic viral hepatitis was significantly higher than that of the control group (P<0.01) . And sCR1 of patients with hepatitis gravis was significantly higher than that of patients with chronic viral hepatitis (P<0.01) , and was related with the changes of CHE, PT and PTA. It was concluded that the changes of sCR1 of hepatitis gravis was related with the damage degree of liver function, and it can be used as reference marker for analyzing of the degree of hepatitis gravis and judging the development and prognoses.
- Hepatitis gravis,
- Serum complement receptor 1 (sCR1) ,
- Liver function

FullText(HTML)

References(8)

References

[1]DiBonaD , MotaltoG , ClemenzaL , etal.Solublecomplementreceptortype1 (sCR1) inchronicliverdisease;serumlevelsatdifferentstagesofliverdiseases[J].ClinExpImmunol, 1998, 114 (1) ∶102-105.

[2]XavierD , SteophaneO , MarcelleT , etal.Catabolismofthehumanery throcyteC3b/C4breceptor (CR1, CD35) :vesiculationand/orproteoly sis[J].Immunopharmacology, 1997, 38 (1) ∶129-140.

[3]PiddlesdenSJ, JiangS , LevinJL , etal.Solublecomplementreceptor1 (sCR1) protectsagainstexperimentalautoimmunemyastheniagravis[J].JNeuroimmunol, 1996, 71 (1-2) ∶173-177.

[4]VriesendorpFJ, FlynnRE , PaollaMA , etal.Solublecomplementre ceptor1 (sCR1) isnotaseffectiveascobravenomfactorinthetreatmentofexperimentalallergicneuritis[J].IntJNeurosci, 1997, 92 (3-4) ∶287-298.

[5] SadallahgS , GiostraE , MenthaG , etal.Increasedlevelsofsolublecomplementreceptor1inserumpatientswithliverdiseases[J].Hepatology, 1996, 24 (1) ∶118-112.

[6]病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (5) ∶324-329.

[7]KantoT , HayashiN , TakeharaT , etal.Lowexpressionoferythrocytescomplementreceptortype1inchronichepatitisCpatients[J].JMedVi rol, 1996, 50∶126-134.

[8]王海滨, 钱宝华, 郭峰, 等.肝病患者红细胞一型补体受体分子基因型与数量表达的变化[J].中华肝脏病杂志, 2000, 8 (6) ∶335-337.

Relative Articles

[1]	Yujie HUANG, Siyi FENG. Application value of two-dimensional shear wave elastography and serological models in the staging of liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2024, 40(3): 509-515. doi: 10.12449/JCH240312
[2]	Zhao Zhao, Qi WenQian, Zhao Ping. Research advances in insulin-like growth factor 1 receptor and its pathway in diagnosis and treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(4): 763-768. doi: 10.3969/j.issn.1001-5256.2017.04.038
[3]	Yan XiaoDi, Dong ZhiZhen, Chen Jie, Qiu LiWei, Wu Wei, Yao DengFu. Dynamic expression profile of the insulin-like growth factor-1 receptor during malignant transformation of hepatocytes[J]. Journal of Clinical Hepatology, 2013, 29(3): 217-222.
[4]	Suo HaiFen, Zhu YaoJu. Effect of sophocarpidine and diammonium glycyrrhizinate injection on hepatic fibrosis and the content of interferon-γ of chronicity type B Hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(2): 196-198.
[6]	Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62.
[7]	Li ChunMing, Huang XiaoYun, Jin YueMing, Gong YuHua, Tan YouWen. Analysis of anti-fibrosis effect of combining lamivudine with captopril in 166 cases with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 102-105.
[8]	Yu HongWei, Meng QingHua, Zhang FenYan, Li Juan, Wang JinHuan, Duan ZhongHui. Research on mechanism of hypoglycemia in Patients with Severe Chronic Hepatitis B.[J]. Journal of Clinical Hepatology, 2008, 24(3): 175-177.
[9]	Xia Qi, Fu JieHai, Cai WeiMin, Liu RongHua. Diagnostic value of AST/PLT and GGT/PLT for hepatic fibrosis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 364-366.
[17]	Kong Li, Li BingShun, Ren ZhongXuan, Hu YunLong, Liu JinXing. The study of inhibitory effect of IFN-α therapy for hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(6): 356-358.
[20]	Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2223) PDF downloads(779)

重型肝炎患者血清sCR1与肝功能损伤程度的相关性研究

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

重型肝炎患者血清sCR1与肝功能损伤程度的相关性研究

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content